Literature DB >> 2509746

Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction.

L K Hine1, N M Laird, P Hewitt, T C Chalmers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2509746

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  19 in total

Review 1.  Surrogate endpoints: a basis for a rational approach.

Authors:  J P Boissel; J P Collet; P Moleur; M Haugh
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Antiarrhythmic therapies for the prevention of sudden cardiac death.

Authors:  F A McAlister; K K Teo
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

3.  Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers.

Authors:  A I Wilk; N M Jensen; T C Havighurst
Journal:  J Gen Intern Med       Date:  1997-05       Impact factor: 5.128

Review 4.  Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction.

Authors:  R D Underwood; J Sra; M Akhtar
Journal:  Clin Cardiol       Date:  1997-09       Impact factor: 2.882

Review 5.  Ventricular arrhythmias in congestive heart failure: clinical significance and management.

Authors:  G R Khoshnevis; A Massumi
Journal:  Tex Heart Inst J       Date:  1999

Review 6.  The pharmacologic treatment of atrial fibrillation.

Authors:  R Bolognesi
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 7.  Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants.

Authors:  M J Kendall; I Rajman; S R Maxwell
Journal:  Postgrad Med J       Date:  1994-05       Impact factor: 2.401

Review 8.  Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death.

Authors:  Marian A Spath; Bernie J O'Brien
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 9.  Number needed to screen: development of a statistic for disease screening.

Authors:  C M Rembold
Journal:  BMJ       Date:  1998-08-01

Review 10.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.